Founder, Ceo
Current4DMedical Limited (ASX:4DX) is a global medical technology company that has created a step change in the capacity to accurately and quickly understand lung function of patients with respiratory diseases.Through its flagship patented XV Technology, 4DMedical enables physicians to understand regional airflow in the lungs and identify respiratory deficiencies earlier and with greater sensitivity as they breathe. This technology powers 4DMedical’s FDA-cleared XV Lung Ventilation Analysis Software (XV LVAS), which is the first and only modality that can dynamically quantify ventilation. It additionally exposes the patient to lower levels of radiation relative to other diagnostic methods, a clear advantage when disease progression and therapeutic effectiveness need to be regularly monitored.XV LVAS reports are prepared utilising 4DMedical’s Software as a Service delivery model using existing hospital imaging equipment or the company’s own revolutionary XV Scanner.To learn more, please visit: www.4dmedical.com/